Labetalol iv dose in bp -258
Labetalol IV is used for hypertensive emergencies. The standard dosing is: 20 mg IV bolus over 2 minutes, then 40-80 mg every 10 minutes as needed (max cumulative dose 300 mg). Alternatively, an IV infusion at 0.5-2 mg/min.
Searching sources...
Reading File
Finding Sources
Reading File
Reading File
Reading File
Now let me look for the specific dosing table from Tintinalli's which has the exact IV doses:
Finding Sources
Reading File
Reading File
Here is the complete, textbook-sourced answer on Labetalol IV dosing in hypertensive emergencies (BP crisis):
Labetalol IV Dose - Hypertensive Emergency
Mechanism
Labetalol is a combined non-selective α₁- and β-blocker (α:β ratio of 1:7 for the IV formulation). It reduces peripheral vascular resistance without reflex tachycardia, while maintaining cerebral, renal, and coronary blood flow.
IV Dosing - Two Methods
Method 1: Intermittent IV Bolus (most common)
| Step | Dose | Timing |
|---|---|---|
| Initial dose | 20 mg IV over 2 min | - |
| Repeat doses | 20-80 mg IV every 10 min | As needed |
| Maximum cumulative dose | 300 mg total | - |
Method 2: Continuous IV Infusion
- 0.5-2 mg/min IV infusion, titrated to effect
Onset and Duration
- Onset of action: 2-5 minutes after IV administration
- Peak effect: 5-15 minutes
- Duration: 2-4 hours
Special Situations
| Situation | Notes |
|---|---|
| Aortic dissection | Preferred agent - 20 mg IV bolus over 2 min, then 20-80 mg every 10 min, then 0.5-2 mg/min infusion |
| Pregnancy / Preeclampsia | Safe to use - starting dose 10-20 mg IV, may double every 10 min up to 80 mg/dose, max 300 mg total |
| Hypertensive encephalopathy | Suitable choice |
| Acute coronary syndrome | Suitable choice |
| Pheochromocytoma | Suitable (combined α + β block) |
IV-to-Oral Conversion
Once BP is controlled with IV labetalol, initiate 200 mg orally, followed by 200-400 mg in 6-12 hours, then 400-2400 mg/day in divided doses based on response.
Contraindications
- Asthma / active bronchospasm
- Decompensated heart failure
- Significant bradycardia or heart block
Sources: Goldman-Cecil Medicine (Table 63-3), Creasy & Resnik's Maternal-Fetal Medicine, Tintinalli's Emergency Medicine, Goodman & Gilman's Pharmacological Basis of Therapeutics
Contra indication
Labetalol is contraindicated in bronchospasm/asthma, decompensated heart failure, significant bradycardia, and heart block. Also avoid in cardiogenic shock.
Searching sources...
Finding Sources
Reading File
Finding Sources
Here is the complete list of Labetalol Contraindications, sourced directly from multiple textbooks:
Labetalol - Contraindications
Absolute Contraindications
| Contraindication | Reason |
|---|---|
| Bronchial Asthma | Non-selective β-blockade causes bronchoconstriction and bronchospasm |
| COPD (with asthmatic component) | Same mechanism - bronchospasm risk |
| Bradycardia | β-blockade further slows the heart rate |
| Heart Block (2nd/3rd degree AV block) | Worsens conduction delay; risk of complete block |
| Decompensated / Congestive Heart Failure | Negative inotropy can worsen cardiac output |
| Cardiogenic Shock | Reduces cardiac output, worsens hemodynamic collapse |
Relative Contraindications
| Contraindication | Notes |
|---|---|
| Hepatic impairment | Labetalol is extensively metabolised by the liver; impaired clearance increases toxicity risk |
| Reactive airway disease | Even without frank asthma, any reactive airway component warrants caution |
| Bradycardia from raised ICP | Bradycardia secondary to increased intracranial pressure is a relative contraindication |
| Peripheral vascular disease | β-blockade can worsen limb ischemia |
Quick Memory Tip
"ABCHH" - Asthma, Bradycardia, Congestive heart failure, Heart block, Hepatic impairment
Sources: Tintinalli's Emergency Medicine (Table 57-6), Comprehensive Clinical Nephrology 7th Ed, Creasy & Resnik's Maternal-Fetal Medicine, Harrison's Principles of Internal Medicine 22E, Lippincott Pharmacology
This is a shared conversation. Sign in to Orris to start your own chat.